China Corruption Probe Spreads To Domestic Industry As Sino Biopharma Feels The Heat
This article was originally published in PharmAsia News
Executive Summary
In the second disclosure this week of a Chinese domestic pharma company under investigation, Sino Biopharmaceutical said it is looking into reports from China’s state television that a majority-owned subsidiary sponsored doctors on overseas trips to Thailand and Taiwan.